Novo Nordisk A/S
NVO
$125.79
-$0.37-0.29%
Headlines
4/26/2024
-
The Motley Fool UK
4/25/2024
-
FiercePharma
4/25/2024
-
Zacks Investment Research
4/25/2024
-
Zacks Investment Research
4/24/2024
-
Zero Hedge
4/24/2024
-
Zacks Investment Research
4/24/2024
-
Quartz
4/24/2024
-
Seeking Alpha - Healthcare
4/24/2024
-
SeekingAlpha.com: All News
4/24/2024
-
CNBC: World News
4/24/2024
-
Ticker Report
4/24/2024
-
Zacks Investment Research
4/24/2024
-
Zacks Investment Research
4/24/2024
-
Ticker Report
4/24/2024
-
InvestorPlace
4/24/2024
-
Fool.com Headlines
4/24/2024
-
Yahoo! Finance: News
4/24/2024
-
CNBC: US News
4/24/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
Ticker Report
4/23/2024
-
Zacks Investment Research
4/23/2024
-
Zacks Investment Research
4/22/2024
-
Fool.com Headlines
4/22/2024
-
The Mercury News: Health
Filings
Wednesday, January 31, 2024
Sunday, December 31, 2023
Beginning of May (est)
Price History
Business Description
--
--
Novo Nordisk A/S, together with its subsidiaries, engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland...
more